Sun Pharma Advanced Research Company Ltd.

The new year promises to be one of multifaceted action in India ranging from deal appetite and growing big pharma interest in global capability centers (GCCs), besides some big-ticket launches, to re

The year gone by saw India Pharma Inc scale new peaks in terms of cutting-edge R&D advances but there were perilous valleys as well as quality issues hit hard, threatening to eclipse the industry’s re

Antibody-drug conjugates (ADCs) represent the next big opportunity in pharma, going by the multiple multi-billion dollar deals struck in recent times. In 2023 alone, the $22bn Merck & Co., Inc. paid

Sun Pharma Advanced Research Company Ltd. (SPARC) is requesting that the US Food and Drug Administration require manufacturers to recall five unapproved phenobarbital sodium products, arguing that th